Soltis Investment Advisors LLC Geron Corp Transaction History
Soltis Investment Advisors LLC
- $1.08 Billion
- Q1 2025
A detailed history of Soltis Investment Advisors LLC transactions in Geron Corp stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 75,000 shares of GERN stock, worth $116,250. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,000
Previous 75,000
-0.0%
Holding current value
$116,250
Previous $265,000
55.09%
% of portfolio
0.01%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
295Shares Held
496MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$93.6 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$72.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$59.2 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$52.9 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$42.2 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $586M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...